Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended 30 June 202304-08-2023
04-08-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On 30 June 2023
Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on 30 June 202304-08-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 04.08.2023
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations'), we enclose herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30 June 2023. The said Results were reviewed and recommended by Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on 04 August 2023. Further, we enclose herewith Limited Review Report issued by M/s. NDJ & Co., Chartered Accountants, (Firm Registration No. 136345W), Statutory Auditors of the Company as required under Regulation 33 of SEBI Listing Regulations. The above information shall be made available on the website of the Company at www.tatvachintan.com. The Board meeting commenced at 11:30 A.M. and concluded at 02:45 P.M.04-08-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter ended 30 June 2023, is scheduled on Friday, 04 August 2023 at 05:00 p.m. (IST). The Call is hosted by Ambit Capital and an invite in this regard is attached for your information and records. The above information is also being made available on the website of the Company at https://www.tatvachintan.com/.28-07-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 04.08.2023
Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30 June 2023. Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''''designated persons'''' regarding the closure of the Trading Window for trading in the Company''s equity shares from 01 July 2023 till the expiry of 48 hours from the date the said financial results are made public. The above information is also being made available on the website of the Company at www.tatvachintan.com.27-07-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisements - Dispatch of Notice of Postal Ballot15-07-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot under Section 110 of the Companies Act, 202314-07-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 11 July 2023
Outcome of the Board Meeting held on 11 July 202311-07-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.202308-07-2023
Tatva Chintan surges 4% as board to consider fund-raise on July 11
The stock has risen 5 percent in the past month but is still down over 15 percent year-to-date07-07-2023